Jürgen Winkler (neurologist)

from Wikipedia, the free encyclopedia

Jürgen Winkler (born December 17, 1958 in Tübingen ) is a German neurologist , neurobiologist and university professor in Erlangen .

Life

Winkler attended the Helmholtz High School in Karlsruhe from 1965 to 1977 . After graduating from high school , he spent two years in the armed forces ; he was released as a lieutenant in the reserve. From 1979 he studied medicine at the Albert Ludwig University of Freiburg and at the Louis Pasteur University in Strasbourg . In 1980 he became a member of the Corps Hubertia Freiburg . After the state examination and the license to practice medicine, he wrote an immunobiological doctoral thesis with Sabine von Kleist . He was magna cum laude Dr. med. PhD . He completed his clinical training in Neurology and Psychiatry in Würzburg (1988–1992) and in La Jolla , University of California, San Diego (1992–1999). Since 1997 at the University of Regensburg , he completed his habilitation there in March 2000. After two years as a private lecturer , he received a C3 professorship for clinical neurobiology on February 1, 2002 . Since 2006 he has been coordinating the Bavarian Research Association for Adult Neural Stem Cells ForNeuroCell . Since 2008, Winkler has been head of the “Molecular Neurology” department at the Neurological University Clinic in Erlangen. Winkler is married and has three children.

Awards

  • McDonnell-Pew Fellowship, Salk Institute, La Jolla (1994)
  • Research Award, Sam and Rose Stein Institute for Research on Aging, San Diego (1995)
  • Brain League Prize, Alzheimer's Society (1996)
  • Japanes Society for Intractable Disorders, Tokyo (1996)
  • National Brookdale Professorship, New York (1997)
  • Business plan competition Northern Bavaria (2003)

Web links

Individual evidence

  1. Kösener Corpslisten 1996, 79/397
  2. Dissertation: Expression of the carcinoembryonic antigen in the first trimester of pregnancy
  3. Habilitation thesis: Regeneration of the cholinergic system: potential implications for the therapy of neurodegenerative diseases